Volume 19 - Number 1 - January 2011

Clinical Geriatrics

02/03/2011
The idea of “brain fitness” as a means to retain cognitive skills is not a new concept to physicians.
02/03/2011
02/03/2011
Barney S. Spivack, MD, FACP, AGSF, CMD
The last several years of SGR-induced uncertainty have taken a toll.
02/03/2011
02/03/2011
Steven R. Gambert, MD, AGSF, MACP
While the winter can be a magical and joyous time of the year, for many it brings life-changing concerns and realistic problems.
02/03/2011
Gout
Gout
02/03/2011
Dean G. Gianakos, MD, FACP; Peter A. H. Gibbs, DO, MS
In elderly patients, soft-tissue infections can be devastating.
02/03/2011
02/03/2011
Shaida Talebreza Brandon, MD; Byron Bair, MD; Roger Kathol, MD
The use of a collaborative care model in the treatment of depression ensures that evidence-based recommendations are carried out correctly and efficiently.
02/03/2011
02/03/2011
Mark A. McElhannon, MD; Sana Muneer, MD
Brain metastases are discovered on imaging studies, with contrast-enhanced MRI being the most sensitive modality available.
02/03/2011
02/03/2011
Richard Grant, MD; Janice Fey, RN, MSN, CRNP; Donna B. Fedus, MA; Jennifer W. Campbell, MA, MSW, PhD
Physician decision-making about NFCE rests solely with clinical evaluation of the patient.
02/03/2011
02/03/2011
Birju B. Patel, MD, FACP; N. Wilson Holland, MD, FACP
Acetylcholinesterase inhibitors (AChEIs) are typically prescribed to treat symptoms of cognitive and functional decline in patients with AD and other dementias.
02/03/2011
Gout
Gout
02/03/2011
Tony C. Ning, MD; Robert T. Keenan, MD, MPH
There are differences in the clinical features and approaches to the treatment of gout in the elderly as compared with the general population.
02/03/2011
01/18/2011
While having good genes certainly helps, a growing body of research suggests that how well you age depends largely on you and what you do.
01/18/2011